Integrating Subclonal Response Heterogeneity to Define Cancer Organoid Therapeutic Sensitivity is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2021). On theSindex it has a DataRank of 0.345. It has been cited 9 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.345
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 5T32AG000213-26
Biology of Aging and Age Related Diseases Training Grant
National Institutes of Health
Grant: 7R01CA185747-03
Cellular level optical metabolic imaging to predict drug response in cancer
National Institutes of Health
Grant: 5P30CA014520-18
CANCER CENTER SUPPORT
National Institutes of Health
Grant: 3T32CA009135-13S1
PREDOCTORAL TRAINING IN EXPERIMENTAL ONCOLOGY
National Institutes of Health
Grant: 5R01CA205101-02
(PQ7) Quantitative in vivo optical imaging of tumor heterogeneity
National Institutes of Health
Grant: 5R01CA211082-02
Optical imaging of pancreas cancer organoids for drug development and personalized treatment
National Institutes of Health
Grant: 5U01TR002383-05
Harnessing human brain and liver microphysiological systems for testing therapeutics for metastatic melanoma
National Institutes of Health
Grant: 5R37CA226526-03
Optical imaging to predict cell-level genetic heterogeneity and treatment sensitivity in colorectal cancer
Fields of Study
Keywords
Sustainable Development Goals